Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Aim To determine the rate of major congenital anomalies in offspring of a large group of women with diabetes mellitus treated with insulin lispro (Humalog®). Methods This multinational, multicentre, retrospective study included mothers with diabetes mellitus (diagnosed prior to conception) who were treated with insulin lispro for at least 1 month before conception and during at least the first trimester of pregnancy. Anomalies were assessed by two independent dysmorphologists not affiliated with the sponsor. Results The charts of 496 women were reviewed for 533 pregnancies resulting in 542 offspring (500 live births, 31 spontaneous and seven elective abortions, and four stillbirths). Mothers’ characteristics: mean (± sd) age was 29.9 (± 5.2) years, 85.6% were Caucasian and 97.2% had Type 1 diabetes mellitus. Insulin lispro continued to be the main mealtime insulin for more than 96% of the women during the second and third trimester. The dysmorphologists determined that 27 (5.4%) offspring had major congenital anomalies and 2 (0.4%) offspring had minor congenital anomalies. Conclusions The rate of major congenital anomalies was 5.4%[95% CI (3.45%, 7.44%)] for offspring of mothers with diabetes mellitus treated with insulin lispro before and during pregnancy. The current published rates of major anomalies in infants born to mothers with diabetes treated with insulin are between 2.1 and 10.9%. This suggests that the anomaly rate with insulin lispro treatment does not differ from the published major congenital anomaly rates for other insulin treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Veciana, M., Major, C. A., Morgan, M. A., Asrat, T., Toohey, J. S., Lien, J. M., & Evans, A. T. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331901 · Cited by 666
Suhonen, L., Hiilesmaa, V., & Teramo, K. (2000) · Diabetologia · doi:10.1007/s001250050010 · Cited by 302
Hanson, U., Persson, B., & Thunell, S. (1990) · Diabetologia · doi:10.1007/bf00401047 · Cited by 176
Insulin lispro and regular insulin in pregnancy
Bhattacharyya, A. (2001) · QJM · doi:10.1093/qjmed/94.5.255 · Cited by 114
Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus
Persson, B., Swahn, M.-L., Hjertberg, R., Hanson, U., Nord, E., Nordlander, E., & Hansson, L.-O. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00141-9 · Cited by 103
Research works printed but not linked: 24
- Buchanan T., 1995, Diabetes in America, 719
- 10.1002/tera.1420390303 · DOI · Paper page
- 10.2337/diacare.19.5.514 · DOI · Paper page
- 10.2337/diacare.26.2007.S91 · DOI
- 10.2337/diab.46.2.265 · DOI · Paper page
- 10.2337/diacare.22.9.1422 · DOI · Paper page
- 10.1080/01443610120059851 · DOI
- 10.1055/s-2002-19987 · DOI
- 10.1046/j.1464-5491.2003.00840.x · DOI · Paper page
- 10.4158/EP.9.3.187 · DOI
- 10.1016/S0022-3476(82)80261-8 · DOI · Paper page
- 10.1016/S0029-7844(02)02242-1 · DOI · Paper page
- Rosenn B, 1994, Glycemic thresholds for spontaneous abortion and congenital malformations in insulin dependent diabetes mellitus, Obstet Gynecol, 84, 515
- 10.1001/jama.1991.03460060063025 · DOI · Paper page
- 10.1177/009286159202600108 · doi:10.1177/009286159202600108
- 10.1067/mcp.2001.112364 · DOI
- 10.1007/s004310050752 · DOI
- Becerra JE, 1990, Diabetes mellitus in pregnancy and the risk of specific birth defects: a population based case control study, Pediatrics, 85, 1, 10.1542/peds.85.1.1 · DOI · Paper page
- 10.1046/j.1464-5491.2002.00756.x · DOI
- 10.1002/ajmg.1320510206 · DOI · Paper page
- 10.1016/0002-9378(83)90747-0 · DOI
- Mills JL, 1979, Malformations in infants of diabetic mothers occur before the seventh gestational week Implications for treatment, Diabetes, 28, 292, 10.2337/diab.28.4.292 · DOI · Paper page
- 10.1034/j.1600-0412.2002.811203.x · DOI
- Cypryk K, 2004, Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy, Med Sci Monit, 10, 129
Cited by
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
“Rapid-acting insulin does not increase the risk of teratogenicity (30, 157, 158, 163–165).”
Self-citationPreconception care for women with diabetes and prevention of major congenital malformations
Kitzmiller, J. L., Wallerstein, R., Correa, A., & Kwan, S. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20734 · Cited by 369
Durnwald, C. P., & Landon, M. B. (2008) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050802022797 · Cited by 61
Lapolla, A., Dalfrà, M. G., Spezia, R., Anichini, R., Bonomo, M., Bruttomesso, D., Di Cianni, G., Franzetti, I., Galluzzo, A., Mello, G., et al. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0024-0 · Cited by 58
Metadata
- Authors
- Wyatt, J. W., Frias, J. L., Hoyme, H. E., Jovanovic, L., Kaaja, R., Brown, F., Garg, S., Lee‐Parritz, A., Seely, E. W., Kerr, L., Mattoo, V., Tan, M., & the IONS study group
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2005-05-21
- Volume
- 22
- Issue
- 6
- Pages
- 803-807
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2170631776
- Cited by
- 103
- References
- 5
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. https://app.cochat.ai/papers/10.1111/j.1464-5491.2004.01498.x
- The paper
- Wyatt, J. W., Frias, J. L., Hoyme, H. E., Jovanovic, L., Kaaja, R., Brown, F., Garg, S., Lee‐Parritz, A., Seely, E. W., Kerr, L., Mattoo, V., Tan, M., & the IONS study group. (2005). Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2004.01498.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.